Tainted foreign drugs trigger FDA scrutiny from Congress

The skyrocketing number of firms supplying drugs to the U.S. has outpaced the FDA's ability to track them, according to Capitol Hill testimony.
Posted in Health Insurance, Healthcare, Medicare |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.